Specific Systems of Treatment
Epidemiological studies correlated a lack of vitamin C with a high death rate, including a high cancer death rate. In 1948, a study of 577 older residents of San Mateo County, in California, were interviewed. When researchers followed this up eight years later, they found that the death rate for those receiving the highest amount of dietary vita- min C was only 40% that of those with much smaller amounts of the vitamin (ibid.).
W.J. McCormick, M.D., a Canadian physician, found in 1954 that “the degree of malignancy is determined inversely by the degree of connective tissue resistance, which in turn is dependent upon the adequacy of vitamin C intake” (ibid.). Vitamin C does far more than prevent scurvy; it is the ce- ment in connective tissue throughout your body.
Unlike Coley’s toxins, Durovic’s Krebiozen, or Burton’s vaccines, vitamin C was a clear-cut chemi- cal substance, with properties which had been re- peatedly researched. Yet a storm of protest del- uged Dr. Pauling’s disclosure of these facts.
In 1973, Dr. Morris Shimkin wrote in an NCI publication, Science and Cancer, “There is no diet that prevents cancer in man. Treatment of cancer by diet alone is in the realm of quakery.”
With the help of wealthy friends, Pauling es- tablished the Linus Pauling Institute, for research into, and dissemination of, the value of ascorbic acid and related ingredients in the treatment of cancer.
Ewan Cameron, M.D., was a physician at the Vale of Leven District General Hospital in Loch Lomondside, Scotland. Beginning in 1971, he teamed up with Pauling and began giving terminal cancer patients high doses of vitamin C.
These were patients who had earlier received surgery, radiation, and hormones; only a few had received cytotoxic drugs (chemotherapy). In each instance, two physicians would certify that the case was hopeless and nothing further could be done. Then the patient was turned over to Dr. Cameron.
He immediately began high doses of vita- min C. This was not difficult, since vitamin C has no toxic effects on the body, except that its acidity could injure the teeth or be uncomfort- able in the stomach.
Cameron was a researcher in his own right. He was not only a surgeon, but had studied the biochemistry of cancer cells and found that can- cer spread by invading healthy normal tissue in its vicinity. He found that, to do this, the can- cer cell produced an enzyme, hyaluronidase. This enzyme attacked the intercellular ground cement, the material that holds cells together
in tissues. He published his findings in a 1966 book, Hyaluronidase and Cancer.
Then Cameron set to work to find a substance which would strengthen the intercellular cement and thus slow the growth of cancer. He thought it would be a hormone,—but he discovered that it was vitamin C which other researchers had shown was a powerful builder of this cell cement.
Scotland, with a rather high-meat consump- tion, has a high rate of cancer; and 90% of the cancer patients in his area were sent to Cameron’s hospital, whose surgical unit was under his direc- tion. In addition, his clinical work was supported by Scotland’s Secretary of State, as well as by the Linus Pauling Institute.
The testing by Cameron began in 1971, and Pauling described what happened when vitamin C—with the addition of no other nutrients or life changes—was given to the cancer patients:
“Dr. Cameron first noticed that the patients felt well when they received 10 grams a day or more of vitamin C. They developed good appe- tites, increased energy, got up from the hospi- tal, went home, went back to work and got along much better than with conventional therapy. Pa- tients who were on morphine for pain could be taken off their morphine in five days.”—Linus Pauling, quoted in H.L. Newbold, “Design for Living,” interview by Carleton Fredericks, Ph.D., WOR-AM, New York, May 9, 1978. Although these results were excellent, it was necessary to begin a detailed study of 100 ter- minally ill cancer patients who were beyond fur- ther help by orthodox methods of treatment.
The final results revealed that patients, re- ceiving 10 grams a day of vitamin C, lived, on the average, four times as long after having reached the terminal stage than those who re- ceived only the conventional therapy. In addi- tion, the pain was removed, and they felt so much better.
About 16% of Cameron’s cases experienced a dramatically marked increase in survival time. In the control group, the mean average was 50 days; in Cameron’s group, every patient lived more than a year.
(Of course, if other nutritional and life changes had been made, the improvement probably could have been much greater. The most complete sys- tem of nutrition and cleansing, the Gerson method, requires far wider changes; but, consequently, it has far greater success.)
By the early 1980s, Cameron had over 4,000 cases in his records. He has found that the results are far better when he can work on patients in the early stages of cancer.